Cargando…
Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo
Hepatic fibrosis is an effusive wound healing process, characterized by an excessive deposition of extracellular matrix (ECM), as the consequence of chronic liver injury of any etiology. Current therapeutic repertoire for hepatic fibrosis is limited to withdrawal of the noxious agent, which is not a...
Autores principales: | Wang, Ying, Zhang, Xiaoyuan, Yang, Yang, Yang, Xiaohong, Ye, Boping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557020/ https://www.ncbi.nlm.nih.gov/pubmed/26295240 http://dx.doi.org/10.3390/md13085201 |
Ejemplares similares
-
Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study
por: El-Lakkany, Naglaa M., et al.
Publicado: (2018) -
Expression, Purification and Bioactivities Analysis of Recombinant Active Peptide from Shark Liver
por: Lv, Zhengbing, et al.
Publicado: (2009) -
Investigating the antifibrotic effect of the antiparasitic drug Praziquantel in in vitro and in vivo preclinical models
por: Nono, Justin Komguep, et al.
Publicado: (2020) -
Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?
por: Chang, Yue, et al.
Publicado: (2020) -
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
por: Ismail, Mona H, et al.
Publicado: (2011)